27. Depression: The Psychedelic Cure | Katya Malievskaia&George Goldsmith - a podcast by Rob Reid

The largest-ever clinical trial of a psychedelic drug will soon begin in Europe and North America. The drug is psilocybin - the active ingredient in magic mushrooms. The target is treatment-resistant depression.

Further episodes of The After On Podcast

Further podcasts by Rob Reid

Website of Rob Reid